Neuronetics (STIM) Competitor Comparison
We are evaluating the key criteria listed to compare Neuronetics (STIM) against its competitors in the Diagnostics & Research industry.
Market Capitalization
44 / 58Gross Profits
39 / 52Total Revenue
41 / 57EBITDA
40 / 56Free Cashflow
46 / 56Quick Ratio
20 / 57Earnings per Share
34 / 57Dividend yield
0 / 8Total Cash
42 / 57Performance 3 years
46 / 58Performance 5 years
51 / 58Performance 10 years
52 / 58Linearity 3 years
40 / 58Linearity 5 years
39 / 58Linearity 10 years
36 / 58Total Rank
28 / 58Dividend Rank
26 / 58Valuation Rank
52 / 58Piotroski Rank
43 / 58Muliplier Rank
26 / 58Total Revenue - STIM ranking 41 / 57
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.